Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3165 EUR | +0.48% | -6.77% | -18.85% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.85% | 13.98M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.53% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Transcript : Celyad Oncology SA, H1 2022 Earnings Call, Aug 05, 2022